Allurion Stock Triples on Plan to Test Gastric Balloon With Obesity Drugs
Key Takeaways Allurion Technologies said it planned to test its gastric balloon with the key ingredient in popular ...
Wall Street Breakfast Podcast: Allurion Soars On Balloon And GLP-1 Study Plans
Allurion stock soars on weight-loss therapy update. Stardust Power breaks ground on Oklahoma lithium refinery. OpenAI ...
Yahoo Finance6d
Allurion Stock Triples on Plan to Test Gastric Balloon With Obesity Drugs
Allurion Technologies announced it would begin a study to see if its gastric balloon, combined with popular GLP-1 medicines like Novo Nordisk's Wegovy, could improve muscle mass and overall body ...
Allurion Technologies Shares Are Up Today: What's Going On?
Allurion Technologies (NYSE: ALUR) shares are moving higher Friday potentially after after the company announced plans to ...
This Little-Known Stock Just Doubled on Weight-Loss Drug News. Analysts Think It Has 400% Upside Potential From Here.
Detailed price information for Novo Nordisk A/S ADR (NVO-N) from The Globe and Mail including charting and trades.
bovnews6d
What’s Behind Allurion’s (ALUR) Surprising Stock Surge?
This is where Allurion’s unique approach comes into play. Previous studies have demonstrated that patients using the Allurion Gastric Balloon in combination with the Allurion Virtual Care Suite ...
Business Wire6d
Allurion to Raise Approximately $7.4 Million of Gross Proceeds in Offering Priced At-the-Market
The Allurion Program is a weight-loss platform that combines the Allurion Gastric Balloon, the world’s first and only swallowable, procedure-less TM gastric balloon for weight loss, the Allurion ...
Allurion extends rally despite $7.4M stock and warrants offering
Allurion Technologies (ALUR) stock climbed 200% despite a ~7.4M stock and warrants offering announced by the company. Read ...